… DixonWGSymmonsDPMWhat effects might anti-TNF[alpha] therapy be expected to have
on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNF[…

… Systemic inflammation associated with rheumatoid disease appears to account for a large
proportion of this unexplained risk of CV death in the RA population. After adjustment for …

… A recent meta-analysis indicates that rheumatic diseases raise the risk of premature
atherosclerosis, implying that inflammatory conditions such as in rheumatic diseases could have …

… As with RA, not all cardiovascular morbidity and mortality in spondylarthropathies can be
attributed to atherosclerosis. In patients with AS, aortitis involving the aortic root and the …

… , cardiovascular (CV) disease (CVD) is the most relevant. In this chapter, we will focus on the
CV morbidity of the most prevalent IRD: rheumatoid … Other diseases included in the group of …

… rates higher than expected have been reported in most rheumatic conditions, … or cardiovascular
diseases, although the causes of death often are not identified as the rheumatic disease. …

… rheumatic diseases. Better understanding of the association between these conditions and
cardiovascular morbidities … -term outcomes in patients with inflammatory rheumatic disease. …

… impact on premature mortality in workers with inflammatory rheumatic diseases has not been
… cardiovascular comorbidity and mortality in workers with inflammatory rheumatic diseases …

… rheumatic diseases are associated with an excess risk of cardiovascular disease (CVD), as
… renewed interest in CVD risk in the rheumatic diseases. Over the past decade, substantial …

… After 5 years, AS was the chronic inflammatory rheumatic disease more commonly … first
cardiovascular event did not show differences among chronic inflammatory rheumatic diseases. …